This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
20 May 2011

EMA Discusses Pharmacovigilance with French IGAS

The European Medicines Agency hosted a meeting with the French General Inspectorate of Social Affairs to discuss the current system of the safety monitoring of medicines in the EU.

On Tuesday 17 May, the European Medicines Agency hosted a meeting with the French General Inspectorate of Social Affairs (IGAS) to discuss the current system of the safety monitoring of medicines in the European Union (EU). The meeting formed part of IGAS's ongoing review of pharmacovigilance and medicines regulation in France.

 

The meeting focused on:
1. the development of the systems of medicines regulation and pharmacovigilance in the EU since the Agency's establishment in 1995;
2. the initiatives taken to reinforce pharmacovigilance in the EU over recent years;
3. the opportunities provided by the new EU pharmacovigilance legislation, including strengthened pharmacovigilance and the increased promotion and protection of public health.

Related News